Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 8421 | 1185 | 45.3 | 86% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 728 | 12031 | BRAIN DERIVED NEUROTROPHIC FACTOR//BDNF//NERVE GROWTH FACTOR |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | TANEZUMAB | Author keyword | 38 | 86% | 2% | 19 |
| 2 | NGF SECT | Address | 10 | 61% | 1% | 11 |
| 3 | NEUROBIOL MOL MED | Address | 9 | 14% | 5% | 60 |
| 4 | TRKANGFR | Author keyword | 6 | 80% | 0% | 4 |
| 5 | TRKB NEUROTROPHIN RECEPTOR | Author keyword | 4 | 75% | 0% | 3 |
| 6 | MED INFECT P DIS | Address | 3 | 100% | 0% | 3 |
| 7 | PHYSIOL VESALGASSE 1 | Address | 3 | 100% | 0% | 3 |
| 8 | CLIN CHEM MOL DIAGNOST | Address | 3 | 12% | 2% | 25 |
| 9 | CELLULAR TISSUE ENGN | Address | 3 | 45% | 0% | 5 |
| 10 | NGF RECEPTORS | Author keyword | 3 | 27% | 1% | 9 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | TANEZUMAB | 38 | 86% | 2% | 19 | Search TANEZUMAB | Search TANEZUMAB |
| 2 | TRKANGFR | 6 | 80% | 0% | 4 | Search TRKANGFR | Search TRKANGFR |
| 3 | TRKB NEUROTROPHIN RECEPTOR | 4 | 75% | 0% | 3 | Search TRKB+NEUROTROPHIN+RECEPTOR | Search TRKB+NEUROTROPHIN+RECEPTOR |
| 4 | NGF RECEPTORS | 3 | 27% | 1% | 9 | Search NGF+RECEPTORS | Search NGF+RECEPTORS |
| 5 | TROPOMYOSIN RELATED KINASE | 3 | 42% | 0% | 5 | Search TROPOMYOSIN+RELATED+KINASE | Search TROPOMYOSIN+RELATED+KINASE |
| 6 | TRKA NEUROTROPHIN RECEPTOR | 2 | 67% | 0% | 2 | Search TRKA+NEUROTROPHIN+RECEPTOR | Search TRKA+NEUROTROPHIN+RECEPTOR |
| 7 | NGF NERVE GROWTH FACTOR | 2 | 29% | 1% | 6 | Search NGF+NERVE+GROWTH+FACTOR | Search NGF+NERVE+GROWTH+FACTOR |
| 8 | NEUROTROPHIN RECEPTORS | 2 | 11% | 1% | 14 | Search NEUROTROPHIN+RECEPTORS | Search NEUROTROPHIN+RECEPTORS |
| 9 | FULRANUMAB | 1 | 100% | 0% | 2 | Search FULRANUMAB | Search FULRANUMAB |
| 10 | LEVI MONTALCINI | 1 | 100% | 0% | 2 | Search LEVI+MONTALCINI | Search LEVI+MONTALCINI |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | FACTOR ENHANCES SURVIVAL | 49 | 94% | 1% | 17 |
| 2 | NGF | 20 | 12% | 13% | 151 |
| 3 | FUNCTIONAL TRKA | 15 | 71% | 1% | 12 |
| 4 | FACTOR PREVENTS APOPTOSIS | 11 | 78% | 1% | 7 |
| 5 | FACTOR EYE DROPS | 9 | 83% | 0% | 5 |
| 6 | SURVIVAL PROMOTION | 9 | 83% | 0% | 5 |
| 7 | BDNF SECRETION | 8 | 100% | 0% | 5 |
| 8 | PRODUCE NEUROTROPHINS | 8 | 100% | 0% | 5 |
| 9 | NGF RECEPTORS | 7 | 43% | 1% | 12 |
| 10 | FACTOR NGF | 7 | 13% | 4% | 49 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| A systematic review of the efficacy and general safety of antibodies to NGF in the treatment of OA of the hip or knee | 2015 | 1 | 22 | 77% |
| Nerve growth factor: from the early discoveries to the potential clinical use | 2012 | 46 | 189 | 40% |
| Nerve growth factor: an update on the science and therapy | 2013 | 16 | 33 | 55% |
| Neurotrophins and the immune system | 2003 | 106 | 238 | 57% |
| Nerve growth factor: Neurotrophin or cytokine? | 2003 | 61 | 56 | 80% |
| Nerve growth factor as an angiogenic factor | 2008 | 67 | 60 | 40% |
| The role of neurotrophins in the pathophysiology of allergic rhinitis | 2010 | 22 | 40 | 83% |
| Antagonism of Nerve Growth Factor-TrkA Signaling and the Relief of Pain | 2011 | 51 | 143 | 31% |
| Nerve Growth Factor as a Signaling Molecule for Nerve Cells and also for the Neuroendocrine-Immune Systems | 2009 | 39 | 111 | 50% |
| Novel class of pain drugs based on antagonism of NGF | 2006 | 146 | 64 | 33% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | NGF SECT | 10 | 61% | 0.9% | 11 |
| 2 | NEUROBIOL MOL MED | 9 | 14% | 5.1% | 60 |
| 3 | MED INFECT P DIS | 3 | 100% | 0.3% | 3 |
| 4 | PHYSIOL VESALGASSE 1 | 3 | 100% | 0.3% | 3 |
| 5 | CLIN CHEM MOL DIAGNOST | 3 | 12% | 2.1% | 25 |
| 6 | CELLULAR TISSUE ENGN | 3 | 45% | 0.4% | 5 |
| 7 | ALLERGY ASTHMA CLIN | 3 | 30% | 0.6% | 7 |
| 8 | BHARATI MED HOSP | 2 | 27% | 0.7% | 8 |
| 9 | P MED MED SOLNA | 1 | 100% | 0.2% | 2 |
| 10 | PEDIAT PULMONOL ALLERGY CLIN IMMUNOL | 1 | 29% | 0.3% | 4 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000230221 | INSERM CJF 9313//OREGON REG PRIMATE NEUROSCI//ENDOCRINOL BIOL REPROD |
| 2 | 0.0000228831 | AZ64//TROPOMYOSIN RECEPTOR KINASES//CEP 701 |
| 3 | 0.0000194135 | NERVE GROWTH FACTOR//NEUROTROPHIN 3//NEUROTROPHIN |
| 4 | 0.0000167021 | P75NTR//P75 NEUROTROPHIN RECEPTOR//PRONGF |
| 5 | 0.0000096463 | PARASYMPATHETIC NERVES//ALLERGIC GUINEA PIGS//ALUMINIA |
| 6 | 0.0000094289 | BRAIN DERIVED NEUROTROPHIC FACTOR//BDNF//VAL66MET |
| 7 | 0.0000078168 | BRAIN MAST CELLS//THALAMIC MAST CELLS//RING DOVES |
| 8 | 0.0000068846 | NEUROSYST//MOL NEUROBIOL PAIN//BMS182874 5 DIMETHYLAMINO N 3 4 DIMETHYL 5 ISOXAZOLYD 1 NAPHTHALENESULFONAMIDE |
| 9 | 0.0000068703 | AG ENTWICKLUNGSNEUROBIOL//TRKB//7 8 DIHYDROXYFLAVONE |
| 10 | 0.0000048526 | HEMOKININ 1//NEUROKININ 1 RECEPTOR//NK 1R |